Ardelyx President and CEO Sells 41,000 Shares for $243,000
This biotech innovator in gastrointestinal and kidney therapies reported a notable insider sale amid routine portfolio adjustments.
Source: www.fool.com
This biotech innovator in gastrointestinal and kidney therapies reported a notable insider sale amid routine portfolio adjustments.